查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1493251

肺癌液态切片市场规模、份额、趋势分析报告：按样本类型、按生物标记、按技术、按最终用途、按临床应用、按产品、按地区、细分市场预测，2024-2030年

Lung Cancer Liquid Biopsy Market Size, Share & Trends Analysis Report By Sample Type, By Biomarker, By Technology, By End-use, By Clinical Application, By Product, By Region, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 120 Pages | 商品交期: 2-10个工作天内

价格

肺癌液态切片市场的成长和趋势：

Grand View Research, Inc.最新报告显示，预计2030年全球肺癌液态切片市场规模将达23.5亿美元，2024年至2030年复合年增长率为13.3%。

液态切片提供了传统组织切片检查的非侵入性替代方案，可以早期发现肺癌。诊断产业正向精准医疗迈进，这需要准确、全面的诊断工具。液态切片是一种很有前景的解决方案，可为个人化治疗计划提供资讯。

由于发现晚期和死亡率高等因素，整体存活率较低。吸烟和接触烟草等生活方式习惯是一些重要的危险因素，约占全球肺癌病例的 80%。根据世界卫生组织（WHO）统计，2020年全球有22.3%的人口消费烟草，其中男性为36.7%，女性为7.8%。烟草每年还造成超过 800 万人死亡，其中估计有 130 万名二手烟者。

公司正在推出新技术和产品来筛检肺癌。例如，德尔福诊断公司于 2023 年 10 月推出了一项血液检查来筛检肺癌。预计新产品的推出量增加将推动市场发展。

肺癌液态切片市场报告亮点

  • 根据样本类型，基于血液样本的细分市场在 2023 年占据主导地位。这是由于这种样本类型的非侵入性、可重复性、即时监测能力、早期检测和成本效益。
  • 根据生物标记，循环核酸片段将在 2023 年引领市场，因为即使癌症处于早期阶段，也可以在血液样本中以非常低的浓度检测到它们。
  • 从技术来看，多基因平行分析（NGS）领域将在 2023 年占据市场主导地位。
  • 由于肺癌盛行率增加、生活方式改变、医疗保健进步和报销政策的可用性等因素，北美在 2023 年将主导肺癌液态切片市场。
  • 例如，根据美国癌症协会期刊报道，2022 年美国将新增约 1,918,030 例癌症病例，其中每天约有 350 例死于肺癌，这是癌症死亡的主要原因。

目录

第一章调查方法和范围

第 2 章执行摘要

第三章肺癌液态切片市场变数、趋势和范围

  • 市场体系展望
    • 母市场展望
    • 相关/附随市场展望
  • 市场动态
    • 市场推动要素分析
    • 市场限制因素分析
  • 肺癌液态切片市场分析工具
    • 产业分析-波特五力分析
    • PESTEL分析

第四章肺癌液态切片市场：样本类型估计和趋势分析

  • 样本类型市场占有率，2023 年和 2030 年
  • 细分仪表板
  • 按样本类型分類的肺癌液态切片市场展望
  • 2018-2030年市场规模、预测及趋势分析
  • 基于血液样本
  • 其他的

第五章肺癌液态切片市场：生物标记估计和趋势分析

  • 2023年及2030年生物标记物市场占有率
  • 细分仪表板
  • 基于生物标誌物的肺癌液态切片市场前景
  • 2018-2030年市场规模、预测及趋势分析
  • 循环核酸
  • CTC
  • 胞外体/微泡
  • 循环蛋白

第六章肺癌液态切片市场：技术评估与趋势分析

  • 2023年及2030年技术市场占有率
  • 细分仪表板
  • 按技术前景分類的肺癌液态切片市场
  • 2018-2030年市场规模、预测及趋势分析
  • 多基因并行分析（NGS）
  • 单基因分析（PCR 微阵列）

第七章肺癌液态切片市场：最终用途估计和趋势分析

  • 2023 年及 2030 年最终用途市场占有率
  • 细分仪表板
  • 肺癌液态切片市场：最终用途展望
  • 2018-2030年市场规模、预测及趋势分析
  • 医院/实验室
  • 专科诊所
  • 学术/研究中心
  • 其他的

第八章肺癌液态切片市场：临床应用预估及趋势分析

  • 2023 年和 2030 年临床应用市场占有率
  • 细分仪表板
  • 肺癌液态切片市场临床应用前景
  • 2018-2030年市场规模、预测及趋势分析
  • 医院/实验室
  • 专科诊所
  • 学术/研究中心
  • 其他的

第九章肺癌液态切片市场：产品评估和趋势分析

  • 2023年及2030年产品市场占有率
  • 细分仪表板
  • 肺癌液态切片市场：按产品分类的前景
  • 2018-2030年市场规模、预测及趋势分析
  • 装置
  • 消费性套件/试剂
  • 软体服务

第10章肺癌液态切片市场：区域估计与趋势分析

  • 2023 年和 2030 年按地区分類的市场占有率份额
  • 肺癌液态切片市场的区域展望
  • 2018-2030年市场规模、预测及趋势分析
  • 北美洲
  • 欧洲
  • 亚太地区
  • 拉丁美洲
  • 中东/非洲

第十一章竞争格局

  • 主要市场参与企业的最新趋势和影响分析
  • 公司/竞争对手分类
  • 供应商情况
  • 公司简介
    • Agilent Technologies Inc.
    • Bio-Rad Laboratories, Inc.
    • CARDIFF ONCOLOGY, INC.
    • CareDx
    • Eurofins Scientific
    • Exact Sciences Corporation
    • F. Hoffmann-La Roche Ltd
    • Guardant Health
    • Illumina, Inc.
    • LungLife AI, Inc.
    • Myriad Genetics, Inc.
    • Natera, Inc.
    • QIAGEN
    • Thermo Fisher Scientific Inc.
Product Code: GVR-4-68040-267-0

Lung Cancer Liquid Biopsy Market Growth & Trends:

The global lung cancer liquid biopsy market size is anticipated to reach USD 2.35 billion by 2030, growing at a CAGR of 13.3% from 2024 to 2030, according to a new report by Grand View Research, Inc. Liquid biopsies offer a non-invasive alternative to traditional tissue biopsies, enabling earlier detection of lung cancer. The diagnostics industry is moving towards precision medicine, which requires accurate and comprehensive diagnostic tools. Liquid biopsies offer a promising solution for providing information for personalized treatment plans.

Factors such as late detection and high mortality rates result in a decline in the overall survival rate. Lifestyle habits such as cigarette smoking and tobacco exposure are some of the significant risk factors, contributing to approximately 80% of the total lung cancer cases worldwide. According to the World Health Organization (WHO), in 2020, 22.3% of the world's population consumed tobacco, which constitutes 36.7% of men and 7.8% of the total women. It also states that tobacco causes the deaths of more than 8 million people each year, including an estimated 1.3 million passive smokers.

Companies are launching newer technologies and products to screen lung cancers. For instance, Delfi Diagnostics launched its blood test to screen for lung cancer in October 2023. This increasing number of launches involving newer launches is anticipated to propel the market.

Lung Cancer Liquid Biopsy Market Report Highlights:

  • Based on sample type, the blood sample-based segment dominated the market in 2023. This can be attributed to the non-invasive nature, repeatability, real-time monitoring capabilities, early detection, and cost-effectiveness of this sample type.
  • Based on biomarker, the circulating nucleic acids segment led the market in 2023 as it can be detected at very low concentrations in blood samples, even when cancer is at an early stage.
  • Based on technology, the multi-gene-parallel analysis (NGS) segment dominated the market in 2023.
  • North America dominated the market for lung cancer liquid biopsy in 2023, owing to factors such as the increasing prevalence of lung cancer, changes in lifestyles, advancements in healthcare, and availability of reimbursement policies.
  • For instance, according to the American Cancer Society Journals, in 2022, approximately 1,918,030 new cancer cases were observed in the U.S., which included approximately 350 deaths each day from lung cancer, the leading cause of cancer death.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Sample Type
    • 1.2.2. Biomarker
    • 1.2.3. Technology
    • 1.2.4. End-use
    • 1.2.5. Clinical Application
    • 1.2.6. Product
    • 1.2.7. Estimates and forecasts timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Volume price analysis (Model 2)
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Sample Type Outlook
    • 2.2.2. Biomarker Outlook
    • 2.2.3. Technology Outlook
    • 2.2.4. End-use Outlook
    • 2.2.5. Clinical Application Outlook
    • 2.2.6. Product Outlook
  • 2.3. Competitive Insights

Chapter 3. Lung Cancer Liquid Biopsy Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
    • 3.2.2. Market restraint analysis
  • 3.3. Lung Cancer Liquid Biopsy Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Technological landscape
      • 3.3.2.3. Economic landscape

Chapter 4. Lung Cancer Liquid Biopsy Market: Sample Type Estimates & Trend Analysis

  • 4.1. Sample Type Market Share, 2023 & 2030
  • 4.2. Segment Dashboard
  • 4.3. Lung Cancer Liquid Biopsy Market by Sample Type Outlook
  • 4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 4.4.1. Blood Sample Based
      • 4.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.2. Others
      • 4.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. Lung Cancer Liquid Biopsy Market: Biomarker Estimates & Trend Analysis

  • 5.1. Biomarker Market Share, 2023 & 2030
  • 5.2. Segment Dashboard
  • 5.3. Lung Cancer Liquid Biopsy Market by Biomarker Outlook
  • 5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 5.4.1. Circulating Nucleic Acids
      • 5.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.4.2. CTC
      • 5.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.4.3. Exosomes/Microvesicles
      • 5.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.4.4. Circulating Proteins
      • 5.4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. Lung Cancer Liquid Biopsy Market: Technology Estimates & Trend Analysis

  • 6.1. Technology Market Share, 2023 & 2030
  • 6.2. Segment Dashboard
  • 6.3. Lung Cancer Liquid Biopsy Market by Technology Outlook
  • 6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 6.4.1. Multi-gene-parallel Analysis (NGS)
      • 6.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.4.2. Single Gene Analysis (PCR Microarrays)
      • 6.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. Lung Cancer Liquid Biopsy Market: End-use Estimates & Trend Analysis

  • 7.1. End-use Market Share, 2023 & 2030
  • 7.2. Segment Dashboard
  • 7.3. Lung Cancer Liquid Biopsy Market by End-use Outlook
  • 7.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 7.4.1. Hospitals and Laboratories
      • 7.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.2. Specialty Clinics
      • 7.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.3. Academic and Research Centers
      • 7.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.4. Others
      • 7.4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 8. Lung Cancer Liquid Biopsy Market: Clinical Application Estimates & Trend Analysis

  • 8.1. Clinical Application Market Share, 2023 & 2030
  • 8.2. Segment Dashboard
  • 8.3. Lung Cancer Liquid Biopsy Market by Clinical Application Outlook
  • 8.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 8.4.1. Therapy Selection
      • 8.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.4.2. Treatment Monitoring
      • 8.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.4.3. Early Cancer Screening
      • 8.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.4.4. Recurrence Monitoring
      • 8.4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.4.5. Others
      • 8.4.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 9. Lung Cancer Liquid Biopsy Market: Product Estimates & Trend Analysis

  • 9.1. Product Market Share, 2023 & 2030
  • 9.2. Segment Dashboard
  • 9.3. Lung Cancer Liquid Biopsy Market by Product Outlook
  • 9.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 9.4.1. Instruments
      • 9.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.4.2. Consumables Kits and Reagents
      • 9.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.4.3. Software and Services
      • 9.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 10. Lung Cancer Liquid Biopsy Market: Region Estimates & Trend Analysis

  • 10.1. Regional Market Share, 2023 & 2030
  • 10.2. Lung Cancer Liquid Biopsy Market by Region Outlook
  • 10.3. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the Following
    • 10.3.1. North America
      • 10.3.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 10.3.1.2. U.S.
      • 10.3.1.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 10.3.1.3. Canada
      • 10.3.1.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 10.3.2. Europe
      • 10.3.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 10.3.2.2. UK
      • 10.3.2.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 10.3.2.3. Germany
      • 10.3.2.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 10.3.2.4. France
      • 10.3.2.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 10.3.2.5. Italy
      • 10.3.2.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 10.3.2.6. Spain
      • 10.3.2.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 10.3.2.7. Denmark
      • 10.3.2.7.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 10.3.2.8. Sweden
      • 10.3.2.8.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 10.3.2.9. Norway
      • 10.3.2.9.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 10.3.3. Asia Pacific
      • 10.3.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 10.3.3.2. Japan
      • 10.3.3.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 10.3.3.3. China
      • 10.3.3.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 10.3.3.4. India
      • 10.3.3.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 10.3.3.5. Thailand
      • 10.3.3.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 10.3.3.6. South Korea
      • 10.3.3.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 10.3.3.7. Australia
      • 10.3.3.7.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 10.3.4. Latin America
      • 10.3.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 10.3.4.2. Brazil
      • 10.3.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 10.3.4.3. Mexico
      • 10.3.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 10.3.4.4. Argentina
      • 10.3.4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 10.3.5. Middle East and Africa
      • 10.3.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 10.3.5.2. South Africa
      • 10.3.5.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 10.3.5.3. Saudi Arabia
      • 10.3.5.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 10.3.5.4. UAE
      • 10.3.5.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 10.3.5.5. Kuwait
      • 10.3.5.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 11. Competitive Landscape

  • 11.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 11.2. Company/Competition Categorization
  • 11.3. Vendor Landscape
    • 11.3.1. List of key distributors and channel partners
    • 11.3.2. Key customers
    • 11.3.3. Key company heat map analysis, 2023
  • 11.4. Company Profiles
    • 11.4.1. Agilent Technologies Inc.
      • 11.4.1.1. Company overview
      • 11.4.1.2. Financial performance
      • 11.4.1.3. Product benchmarking
      • 11.4.1.4. Strategic initiatives
    • 11.4.2. Bio-Rad Laboratories, Inc.
      • 11.4.2.1. Company overview
      • 11.4.2.2. Financial performance
      • 11.4.2.3. Product benchmarking
      • 11.4.2.4. Strategic initiatives
    • 11.4.3. CARDIFF ONCOLOGY, INC.
      • 11.4.3.1. Company overview
      • 11.4.3.2. Financial performance
      • 11.4.3.3. Product benchmarking
      • 11.4.3.4. Strategic initiatives
    • 11.4.4. CareDx
      • 11.4.4.1. Company overview
      • 11.4.4.2. Financial performance
      • 11.4.4.3. Product benchmarking
      • 11.4.4.4. Strategic initiatives
    • 11.4.5. Eurofins Scientific
      • 11.4.5.1. Company overview
      • 11.4.5.2. Financial performance
      • 11.4.5.3. Product benchmarking
      • 11.4.5.4. Strategic initiatives
    • 11.4.6. Exact Sciences Corporation
      • 11.4.6.1. Company overview
      • 11.4.6.2. Financial performance
      • 11.4.6.3. Product benchmarking
      • 11.4.6.4. Strategic initiatives
    • 11.4.7. F. Hoffmann-La Roche Ltd
      • 11.4.7.1. Company overview
      • 11.4.7.2. Financial performance
      • 11.4.7.3. Product benchmarking
      • 11.4.7.4. Strategic initiatives
    • 11.4.8. Guardant Health
      • 11.4.8.1. Company overview
      • 11.4.8.2. Financial performance
      • 11.4.8.3. Product benchmarking
      • 11.4.8.4. Strategic initiatives
    • 11.4.9. Illumina, Inc.
      • 11.4.9.1. Company overview
      • 11.4.9.2. Financial performance
      • 11.4.9.3. Product benchmarking
      • 11.4.9.4. Strategic initiatives
    • 11.4.10. LungLife AI, Inc.
      • 11.4.10.1. Company overview
      • 11.4.10.2. Financial performance
      • 11.4.10.3. Product benchmarking
      • 11.4.10.4. Strategic initiatives
    • 11.4.11. Myriad Genetics, Inc.
      • 11.4.11.1. Company overview
      • 11.4.11.2. Financial performance
      • 11.4.11.3. Product benchmarking
      • 11.4.11.4. Strategic initiatives
    • 11.4.12. Natera, Inc.
      • 11.4.12.1. Company overview
      • 11.4.12.2. Financial performance
      • 11.4.12.3. Product benchmarking
      • 11.4.12.4. Strategic initiatives
    • 11.4.13. QIAGEN
      • 11.4.13.1. Company overview
      • 11.4.13.2. Financial performance
      • 11.4.13.3. Product benchmarking
      • 11.4.13.4. Strategic initiatives
    • 11.4.14. Thermo Fisher Scientific Inc.
      • 11.4.14.1. Company overview
      • 11.4.14.2. Financial performance
      • 11.4.14.3. Product benchmarking
      • 11.4.14.4. Strategic initiatives

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviations
  • Table 3 North America lung cancer liquid biopsy market, by country, 2018 - 2030 (USD Million)
  • Table 4 North America lung cancer liquid biopsy market, by sample type, 2018 - 2030 (USD Million)
  • Table 5 North America lung cancer liquid biopsy market, by biomarker, 2018 - 2030 (USD Million)
  • Table 6 North America lung cancer liquid biopsy market, by technology, 2018 - 2030 (USD Million)
  • Table 7 North America lung cancer liquid biopsy market, by end-use, 2018 - 2030 (USD Million)
  • Table 8 North America lung cancer liquid biopsy market, by clinical application, 2018 - 2030 (USD Million)
  • Table 9 North America lung cancer liquid biopsy market, by product, 2018 - 2030 (USD Million)
  • Table 10 U.S. lung cancer liquid biopsy market, by sample type, 2018 - 2030 (USD Million)
  • Table 11 U.S. lung cancer liquid biopsy market, by biomarker, 2018 - 2030 (USD Million)
  • Table 12 U.S. lung cancer liquid biopsy market, by technology, 2018 - 2030 (USD Million)
  • Table 13 U.S. lung cancer liquid biopsy market, by end-use, 2018 - 2030 (USD Million)
  • Table 14 U.S. lung cancer liquid biopsy market, by clinical application, 2018 - 2030 (USD Million)
  • Table 15 U.S. lung cancer liquid biopsy market, by product, 2018 - 2030 (USD Million)
  • Table 16 Canada lung cancer liquid biopsy market, by sample type, 2018 - 2030 (USD Million)
  • Table 17 Canada lung cancer liquid biopsy market, by biomarker, 2018 - 2030 (USD Million)
  • Table 18 Canada lung cancer liquid biopsy market, by technology, 2018 - 2030 (USD Million)
  • Table 19 Canada lung cancer liquid biopsy market, by end-use, 2018 - 2030 (USD Million)
  • Table 20 Canada lung cancer liquid biopsy market, by clinical application, 2018 - 2030 (USD Million)
  • Table 21 Canada lung cancer liquid biopsy market, by product, 2018 - 2030 (USD Million)
  • Table 22 Europe lung cancer liquid biopsy market, by country, 2018 - 2030 (USD Million)
  • Table 23 Europe lung cancer liquid biopsy market, by sample type, 2018 - 2030 (USD Million)
  • Table 24 Europe lung cancer liquid biopsy market, by biomarker, 2018 - 2030 (USD Million)
  • Table 25 Europe lung cancer liquid biopsy market, by technology, 2018 - 2030 (USD Million)
  • Table 26 Europe lung cancer liquid biopsy market, by end-use, 2018 - 2030 (USD Million)
  • Table 27 Europe lung cancer liquid biopsy market, by clinical application, 2018 - 2030 (USD Million)
  • Table 28 Europe lung cancer liquid biopsy market, by product, 2018 - 2030 (USD Million)
  • Table 29 UK lung cancer liquid biopsy market, by sample type, 2018 - 2030 (USD Million)
  • Table 30 UK lung cancer liquid biopsy market, by biomarker, 2018 - 2030 (USD Million)
  • Table 31 UK lung cancer liquid biopsy market, by technology, 2018 - 2030 (USD Million)
  • Table 32 UK lung cancer liquid biopsy market, by end-use, 2018 - 2030 (USD Million)
  • Table 33 UK lung cancer liquid biopsy market, by clinical application, 2018 - 2030 (USD Million)
  • Table 34 UK lung cancer liquid biopsy market, by product, 2018 - 2030 (USD Million)
  • Table 35 Germany lung cancer liquid biopsy market, by sample type, 2018 - 2030 (USD Million)
  • Table 36 Germany lung cancer liquid biopsy market, by biomarker, 2018 - 2030 (USD Million)
  • Table 37 Germany lung cancer liquid biopsy market, by technology, 2018 - 2030 (USD Million)
  • Table 38 Germany lung cancer liquid biopsy market, by end-use, 2018 - 2030 (USD Million)
  • Table 39 Germany lung cancer liquid biopsy market, by clinical application, 2018 - 2030 (USD Million)
  • Table 40 Germany lung cancer liquid biopsy market, by product, 2018 - 2030 (USD Million)
  • Table 41 France lung cancer liquid biopsy market, by sample type, 2018 - 2030 (USD Million)
  • Table 42 France lung cancer liquid biopsy market, by biomarker, 2018 - 2030 (USD Million)
  • Table 43 France lung cancer liquid biopsy market, by technology, 2018 - 2030 (USD Million)
  • Table 44 France lung cancer liquid biopsy market, by end-use, 2018 - 2030 (USD Million)
  • Table 45 France lung cancer liquid biopsy market, by clinical application, 2018 - 2030 (USD Million)
  • Table 46 France lung cancer liquid biopsy market, by product, 2018 - 2030 (USD Million)
  • Table 47 Italy lung cancer liquid biopsy market, by sample type, 2018 - 2030 (USD Million)
  • Table 48 Italy lung cancer liquid biopsy market, by biomarker, 2018 - 2030 (USD Million)
  • Table 49 Italy lung cancer liquid biopsy market, by technology, 2018 - 2030 (USD Million)
  • Table 50 Italy lung cancer liquid biopsy market, by end-use, 2018 - 2030 (USD Million)
  • Table 51 Italy lung cancer liquid biopsy market, by clinical application, 2018 - 2030 (USD Million)
  • Table 52 Italy lung cancer liquid biopsy market, by product, 2018 - 2030 (USD Million)
  • Table 53 Spain lung cancer liquid biopsy market, by sample type, 2018 - 2030 (USD Million)
  • Table 54 Spain lung cancer liquid biopsy market, by biomarker, 2018 - 2030 (USD Million)
  • Table 55 Spain lung cancer liquid biopsy market, by technology, 2018 - 2030 (USD Million)
  • Table 56 Spain lung cancer liquid biopsy market, by end-use, 2018 - 2030 (USD Million)
  • Table 57 Spain lung cancer liquid biopsy market, by clinical application, 2018 - 2030 (USD Million)
  • Table 58 Spain lung cancer liquid biopsy market, by product, 2018 - 2030 (USD Million)
  • Table 59 Denmark lung cancer liquid biopsy market, by sample type, 2018 - 2030 (USD Million)
  • Table 60 Denmark lung cancer liquid biopsy market, by biomarker, 2018 - 2030 (USD Million)
  • Table 61 Denmark lung cancer liquid biopsy market, by technology, 2018 - 2030 (USD Million)
  • Table 62 Denmark lung cancer liquid biopsy market, by end-use, 2018 - 2030 (USD Million)
  • Table 63 Denmark lung cancer liquid biopsy market, by clinical application, 2018 - 2030 (USD Million)
  • Table 64 Denmark lung cancer liquid biopsy market, by product, 2018 - 2030 (USD Million)
  • Table 65 Sweden lung cancer liquid biopsy market, by sample type, 2018 - 2030 (USD Million)
  • Table 66 Sweden lung cancer liquid biopsy market, by biomarker, 2018 - 2030 (USD Million)
  • Table 67 Sweden lung cancer liquid biopsy market, by technology, 2018 - 2030 (USD Million)
  • Table 68 Sweden lung cancer liquid biopsy market, by end-use, 2018 - 2030 (USD Million)
  • Table 69 Sweden lung cancer liquid biopsy market, by clinical application, 2018 - 2030 (USD Million)
  • Table 70 Sweden lung cancer liquid biopsy market, by product, 2018 - 2030 (USD Million)
  • Table 71 Norway lung cancer liquid biopsy market, by sample type, 2018 - 2030 (USD Million)
  • Table 72 Norway lung cancer liquid biopsy market, by biomarker, 2018 - 2030 (USD Million)
  • Table 73 Norway lung cancer liquid biopsy market, by technology, 2018 - 2030 (USD Million)
  • Table 74 Norway lung cancer liquid biopsy market, by end-use, 2018 - 2030 (USD Million)
  • Table 75 Norway lung cancer liquid biopsy market, by clinical application, 2018 - 2030 (USD Million)
  • Table 76 Norway lung cancer liquid biopsy market, by product, 2018 - 2030 (USD Million)
  • Table 77 Asia Pacific lung cancer liquid biopsy market, by country, 2018 - 2030 (USD Million)
  • Table 78 Asia Pacific lung cancer liquid biopsy market, by sample type, 2018 - 2030 (USD Million)
  • Table 79 Asia Pacific lung cancer liquid biopsy market, by biomarker, 2018 - 2030 (USD Million)
  • Table 80 Asia Pacific lung cancer liquid biopsy market, by technology, 2018 - 2030 (USD Million)
  • Table 81 Asia Pacific lung cancer liquid biopsy market, by end-use, 2018 - 2030 (USD Million)
  • Table 82 Asia Pacific lung cancer liquid biopsy market, by clinical application, 2018 - 2030 (USD Million)
  • Table 83 Asia Pacific lung cancer liquid biopsy market, by product, 2018 - 2030 (USD Million)
  • Table 84 Japan lung cancer liquid biopsy market, by sample type, 2018 - 2030 (USD Million)
  • Table 85 Japan lung cancer liquid biopsy market, by biomarker, 2018 - 2030 (USD Million)
  • Table 86 Japan lung cancer liquid biopsy market, by technology, 2018 - 2030 (USD Million)
  • Table 87 Japan lung cancer liquid biopsy market, by end-use, 2018 - 2030 (USD Million)
  • Table 88 Japan lung cancer liquid biopsy market, by clinical application, 2018 - 2030 (USD Million)
  • Table 89 Japan lung cancer liquid biopsy market, by product, 2018 - 2030 (USD Million)
  • Table 90 China lung cancer liquid biopsy market, by sample type, 2018 - 2030 (USD Million)
  • Table 91 China lung cancer liquid biopsy market, by biomarker, 2018 - 2030 (USD Million)
  • Table 92 China lung cancer liquid biopsy market, by technology, 2018 - 2030 (USD Million)
  • Table 93 China lung cancer liquid biopsy market, by end-use, 2018 - 2030 (USD Million)
  • Table 94 China lung cancer liquid biopsy market, by clinical application, 2018 - 2030 (USD Million)
  • Table 95 China lung cancer liquid biopsy market, by product, 2018 - 2030 (USD Million)
  • Table 96 India lung cancer liquid biopsy market, by sample type, 2018 - 2030 (USD Million)
  • Table 97 India lung cancer liquid biopsy market, by biomarker, 2018 - 2030 (USD Million)
  • Table 98 India lung cancer liquid biopsy market, by technology, 2018 - 2030 (USD Million)
  • Table 99 India lung cancer liquid biopsy market, by end-use, 2018 - 2030 (USD Million)
  • Table 100 India lung cancer liquid biopsy market, by clinical application, 2018 - 2030 (USD Million)
  • Table 101 India lung cancer liquid biopsy market, by product, 2018 - 2030 (USD Million)
  • Table 102 Thailand lung cancer liquid biopsy market, by sample type, 2018 - 2030 (USD Million)
  • Table 103 Thailand lung cancer liquid biopsy market, by biomarker, 2018 - 2030 (USD Million)
  • Table 104 Thailand lung cancer liquid biopsy market, by technology, 2018 - 2030 (USD Million)
  • Table 105 Thailand lung cancer liquid biopsy market, by end-use, 2018 - 2030 (USD Million)
  • Table 106 Thailand lung cancer liquid biopsy market, by clinical application, 2018 - 2030 (USD Million)
  • Table 107 Thailand lung cancer liquid biopsy market, by product, 2018 - 2030 (USD Million)
  • Table 108 South Korea lung cancer liquid biopsy market, by sample type, 2018 - 2030 (USD Million)
  • Table 109 South Korea lung cancer liquid biopsy market, by biomarker, 2018 - 2030 (USD Million)
  • Table 110 South Korea lung cancer liquid biopsy market, by technology, 2018 - 2030 (USD Million)
  • Table 111 South Korea lung cancer liquid biopsy market, by end-use, 2018 - 2030 (USD Million)
  • Table 112 South Korea lung cancer liquid biopsy market, by clinical application, 2018 - 2030 (USD Million)
  • Table 113 South Korea lung cancer liquid biopsy market, by product, 2018 - 2030 (USD Million)
  • Table 114 Australia lung cancer liquid biopsy market, by sample type, 2018 - 2030 (USD Million)
  • Table 115 Australia lung cancer liquid biopsy market, by biomarker, 2018 - 2030 (USD Million)
  • Table 116 Australia lung cancer liquid biopsy market, by technology, 2018 - 2030 (USD Million)
  • Table 117 Australia lung cancer liquid biopsy market, by end-use, 2018 - 2030 (USD Million)
  • Table 118 Australia lung cancer liquid biopsy market, by clinical application, 2018 - 2030 (USD Million)
  • Table 119 Australia lung cancer liquid biopsy market, by product, 2018 - 2030 (USD Million)
  • Table 120 Latin America lung cancer liquid biopsy market, by country, 2018 - 2030 (USD Million)
  • Table 121 Latin America lung cancer liquid biopsy market, by sample type, 2018 - 2030 (USD Million)
  • Table 122 Latin America lung cancer liquid biopsy market, by biomarker, 2018 - 2030 (USD Million)
  • Table 123 Latin America lung cancer liquid biopsy market, by technology, 2018 - 2030 (USD Million)
  • Table 124 Latin America lung cancer liquid biopsy market, by end-use, 2018 - 2030 (USD Million)
  • Table 125 Latin America lung cancer liquid biopsy market, by clinical application, 2018 - 2030 (USD Million)
  • Table 126 Latin America lung cancer liquid biopsy market, by product, 2018 - 2030 (USD Million)
  • Table 127 Brazil lung cancer liquid biopsy market, by sample type, 2018 - 2030 (USD Million)
  • Table 128 Brazil lung cancer liquid biopsy market, by biomarker, 2018 - 2030 (USD Million)
  • Table 129 Brazil lung cancer liquid biopsy market, by technology, 2018 - 2030 (USD Million)
  • Table 130 Brazil lung cancer liquid biopsy market, by end-use, 2018 - 2030 (USD Million)
  • Table 131 Brazil lung cancer liquid biopsy market, by clinical application, 2018 - 2030 (USD Million)
  • Table 132 Brazil lung cancer liquid biopsy market, by product, 2018 - 2030 (USD Million)
  • Table 133 Mexico lung cancer liquid biopsy market, by sample type, 2018 - 2030 (USD Million)
  • Table 134 Mexico lung cancer liquid biopsy market, by biomarker, 2018 - 2030 (USD Million)
  • Table 135 Mexico lung cancer liquid biopsy market, by technology, 2018 - 2030 (USD Million)
  • Table 136 Mexico lung cancer liquid biopsy market, by end-use, 2018 - 2030 (USD Million)
  • Table 137 Mexico lung cancer liquid biopsy market, by clinical application, 2018 - 2030 (USD Million)
  • Table 138 Mexico lung cancer liquid biopsy market, by product, 2018 - 2030 (USD Million)
  • Table 139 Argentina lung cancer liquid biopsy market, by sample type, 2018 - 2030 (USD Million)
  • Table 140 Argentina lung cancer liquid biopsy market, by biomarker, 2018 - 2030 (USD Million)
  • Table 141 Argentina lung cancer liquid biopsy market, by technology, 2018 - 2030 (USD Million)
  • Table 142 Argentina lung cancer liquid biopsy market, by end-use, 2018 - 2030 (USD Million)
  • Table 143 Argentina lung cancer liquid biopsy market, by clinical application, 2018 - 2030 (USD Million)
  • Table 144 Argentina lung cancer liquid biopsy market, by product, 2018 - 2030 (USD Million)
  • Table 145 MEA lung cancer liquid biopsy market, by country, 2018 - 2030 (USD Million)
  • Table 146 MEA lung cancer liquid biopsy market, by sample type, 2018 - 2030 (USD Million)
  • Table 147 MEA lung cancer liquid biopsy market, by biomarker, 2018 - 2030 (USD Million)
  • Table 148 MEA lung cancer liquid biopsy market, by technology, 2018 - 2030 (USD Million)
  • Table 149 MEA lung cancer liquid biopsy market, by end-use, 2018 - 2030 (USD Million)
  • Table 150 MEA lung cancer liquid biopsy market, by clinical application, 2018 - 2030 (USD Million)
  • Table 151 MEA lung cancer liquid biopsy market, by product, 2018 - 2030 (USD Million)
  • Table 152 South Africa lung cancer liquid biopsy market, by sample type, 2018 - 2030 (USD Million)
  • Table 153 South Africa lung cancer liquid biopsy market, by biomarker, 2018 - 2030 (USD Million)
  • Table 154 South Africa lung cancer liquid biopsy market, by technology, 2018 - 2030 (USD Million)
  • Table 155 South Africa lung cancer liquid biopsy market, by end-use, 2018 - 2030 (USD Million)
  • Table 156 South Africa lung cancer liquid biopsy market, by clinical application, 2018 - 2030 (USD Million)
  • Table 157 South Africa lung cancer liquid biopsy market, by product, 2018 - 2030 (USD Million)
  • Table 158 Saudi Arabia lung cancer liquid biopsy market, by sample type, 2018 - 2030 (USD Million)
  • Table 159 Saudi Arabia lung cancer liquid biopsy market, by biomarker, 2018 - 2030 (USD Million)
  • Table 160 Saudi Arabia lung cancer liquid biopsy market, by technology, 2018 - 2030 (USD Million)
  • Table 161 Saudi Arabia lung cancer liquid biopsy market, by end-use, 2018 - 2030 (USD Million)
  • Table 162 Saudi Arabia lung cancer liquid biopsy market, by clinical application, 2018 - 2030 (USD Million)
  • Table 163 Saudi Arabia lung cancer liquid biopsy market, by product, 2018 - 2030 (USD Million)
  • Table 164 UAE lung cancer liquid biopsy market, by sample type, 2018 - 2030 (USD Million)
  • Table 165 UAE lung cancer liquid biopsy market, by biomarker, 2018 - 2030 (USD Million)
  • Table 166 UAE lung cancer liquid biopsy market, by technology, 2018 - 2030 (USD Million)
  • Table 167 UAE lung cancer liquid biopsy market, by end-use, 2018 - 2030 (USD Million)
  • Table 168 UAE lung cancer liquid biopsy market, by clinical application, 2018 - 2030 (USD Million)
  • Table 169 UAE lung cancer liquid biopsy market, by product, 2018 - 2030 (USD Million)
  • Table 170 Kuwait lung cancer liquid biopsy market, by sample type, 2018 - 2030 (USD Million)
  • Table 171 Kuwait lung cancer liquid biopsy market, by biomarker, 2018 - 2030 (USD Million)
  • Table 172 Kuwait lung cancer liquid biopsy market, by technology, 2018 - 2030 (USD Million)
  • Table 173 Kuwait lung cancer liquid biopsy market, by end-use, 2018 - 2030 (USD Million)
  • Table 174 Kuwait lung cancer liquid biopsy market, by clinical application, 2018 - 2030 (USD Million)
  • Table 175 Kuwait lung cancer liquid biopsy market, by product, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value-chain-based sizing & forecasting
  • Fig. 6 QFD modeling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 Lung cancer liquid biopsy market: market outlook
  • Fig. 9 Lung cancer liquid Biopsy Market Competitive Insights
  • Fig. 10 Parent market outlook
  • Fig. 11 Related/ancillary market outlook
  • Fig. 12 Penetration and growth prospect mapping
  • Fig. 13 Lung cancer liquid biopsy market driver impact
  • Fig. 14 Lung cancer liquid biopsy market restraint impact
  • Fig. 15 Lung cancer liquid biopsy market: Sample type movement analysis
  • Fig. 16 Lung cancer liquid biopsy market: Sample type outlook and key takeaways
  • Fig. 17 Blood sample-based market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 18 Others market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 19 Lung cancer liquid biopsy market: Biomarker movement analysis
  • Fig. 20 Lung cancer liquid biopsy market: Biomarker outlook and key takeaways
  • Fig. 21 Circulating nucleic acids market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 22 CTC market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 23 Exosomes/microvesicles market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 24 Circulating proteins market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 25 Lung cancer liquid biopsy market: Technology movement analysis
  • Fig. 26 Lung cancer liquid biopsy market: Technology outlook and key takeaways
  • Fig. 27 Multi-gene-parallel analysis (NGS) market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 28 Single gene analysis (PCR Microarrays) market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 29 Lung cancer liquid biopsy market: End-use movement analysis
  • Fig. 30 Lung cancer liquid biopsy market: End-use outlook and key takeaways
  • Fig. 31 Hospitals and laboratories market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 32 Specialty clinics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 33 Academic and research centers market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 34 Others market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 35 Lung cancer liquid biopsy market: Clinical application movement analysis
  • Fig. 36 Lung cancer liquid biopsy market: Clinical application outlook and key takeaways
  • Fig. 37 Therapy selection market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 38 Treatment monitoring market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 39 Early cancer screening market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 40 Recurrence monitoring market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 41 Others market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 42 Lung cancer liquid biopsy market: Product movement analysis
  • Fig. 43 Lung cancer liquid biopsy market: Product outlook and key takeaways
  • Fig. 44 Instruments market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 45 Consumables kits and reagents market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 46 Software and services market estimates and forecasts, 2018 - 2030 (USD Million)